Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom.
Department of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):527-538. doi: 10.1158/1055-9965.EPI-19-0953. Epub 2020 Jan 8.
The nature of humoral immunity in carcinogenesis remains poorly understood. In this systematic review and meta-analysis, we aimed to evaluate the association of serum immunoglobulin classes with solid cancer and test our hypothesis that the immune escape of tumors is accompanied by dysregulated systemic immunoglobulin class-switching.
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically searched the Cochrane Library, Embase, and MEDLINE/PubMed databases for observational studies investigating the association between serum immunoglobulins (IgA, IgG, and IgM) and histologically confirmed diagnosis of solid cancer in adults. We selected case-control studies, including more than 20 cases, and those explicitly stating that no form of anticancer treatment was administered prior to immunoglobulin measurement. No eligible cohort studies were identified. The primary summary measure was the standardized mean difference (SMD) with 95% confidence intervals (CI) calculated using a random effects model.
Pooling 11 eligible studies comparing serum IgA levels in 1,351 patients and 560 control subjects revealed a statistically significant SMD (1.50; 95% CI, 0.96-2.04). Nonsignificant SMDs were observed for the 14 selected studies investigating serum IgG [SMD, -0.02 (95% CI, -0.22 to 0.18)] and for the 10 studies reporting serum IgM [SMD, 0.11 (95% CI, -0.10 to 0.32)]. Substantial heterogeneity between studies was observed despite sensitivity analysis by immunoglobulin measurement method, control matching, type of cancer, stage of disease, and sequential study exclusion.
Serum immunoglobulin levels in patients diagnosed with solid cancer might be skewed toward class-switching to IgA, possibly reflecting Th2-polarized immunity.
Further combinatorial analyses of serum immunoglobulin isotypes alongside other immune parameters in databases and observational studies are warranted.
体液免疫在癌症发生中的性质仍未得到充分理解。在这项系统评价和荟萃分析中,我们旨在评估血清免疫球蛋白类别与实体瘤的相关性,并验证我们的假设,即肿瘤的免疫逃逸伴随着系统性免疫球蛋白类别转换的失调。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,我们系统地检索了 Cochrane 图书馆、Embase 和 MEDLINE/PubMed 数据库,以查找关于血清免疫球蛋白(IgA、IgG 和 IgM)与成人组织学确诊实体瘤之间相关性的观察性研究。我们选择了病例对照研究,包括 20 多例患者,以及明确表示在免疫球蛋白测量前未进行任何形式的抗癌治疗的研究。未确定符合条件的队列研究。主要汇总指标是使用随机效应模型计算的标准化均数差(SMD)及其 95%置信区间(CI)。
汇总了 11 项比较 1351 例患者和 560 例对照者血清 IgA 水平的研究,发现 SMD 具有统计学意义(1.50;95%CI,0.96-2.04)。对于 14 项研究血清 IgG 的研究[SMD,-0.02(95%CI,-0.22 至 0.18)]和 10 项报告血清 IgM 的研究[SMD,0.11(95%CI,-0.10 至 0.32)],未观察到 SMD 有统计学意义。尽管对免疫球蛋白测量方法、对照匹配、癌症类型、疾病阶段和连续研究排除进行了敏感性分析,但研究之间仍存在显著的异质性。
诊断为实体瘤的患者的血清免疫球蛋白水平可能向 IgA 类别倾斜,这可能反映了 Th2 极化免疫。
需要在数据库和观察性研究中进一步组合分析血清免疫球蛋白亚型以及其他免疫参数。